Embla member 2 has lost 95 lbs and her doctor recently took her off Lisinopril because her blood pressure is normal.

Embla is a turnkey, digital weight care solution built for cost-conscious U.S. employers. We combine GLP-1 microdosing with expert psychology-based coaching to deliver 16.7% average weight loss in 12 months — using 55% less medication. That means better outcomes, fewer side effects, and lower costs. We handle everything end-to-end: providers, prescriptions, pharmacy, PBM, and employee onboarding. No admin burden. No health plan integration. Fully live in 7 days with simple, pay-per-active-member pricing. Founded in Denmark — the home of GLP-1 — Embla is trusted by U.S. health systems and self-funded employers. Our approach is validated by one of the largest real-world GLP-1 studies and supported by partnerships with the University of Copenhagen and biotech giant Novonesis. Affordable GLP-1 coverage starts here.